test3

Find A Clinical Trial

Disease Type: Sarcoma

Trial ID HFB-301001
Sponsor ID HFB-301001-01

A Dose Escalation Study of HFB301001 (OX40 Agonist Antibody) in Adult Patients With Advanced Solid Tumors

Principal Investigator
M. Adham Salkeni, MD, FRCPC
1 Location
Trial ID HFB-200301
Sponsor ID HFB-200301-01

A Phase 1a/1b, Open-Label, Multi-Center, Dose Escalation and Expansion Study of HFB200301 (TNFR2 Agonist Antibody) as a Single Agent and in Combination With Tislelizumab (Anti-PD-1 Antibody) in Adult Patients With Advanced Solid Tumors

Trial ID INBRX-209
Sponsor ID Inhibrx

A Randomized, Blinded, Placebo-Controlled, Phase 2 Study of INBRX-109 in Unrsectable or Metastatic Conventional Chondrosarcoma

2 Locations
Trial ID TTI-621-03
Sponsor ID Trillium Therapeutics

A Phase 1/2 Study of TTI-621 in Combination with Doxorubacin in Patients with Unresectable or Metastatic High-Grade Leiomyosarcoma

1 Location
Trial ID SALA-002-EW16
Sponsor ID Salarius Pharmaceuticals

A Phase I Trial of LSD1 Inhibitor Seclidemstat (SP-2577) with and without Topetecan and Cyclophosphamide in Patients with Relapsed or Refractory Ewing Sarcoma and Select Sarcomas

1 Location